Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3390/PH14121212 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
FAPi)(2) compared to [Lu-177]Lu-DOTA.SA.FAPi. [Lu-177]Lu-DOTAGA.(SA.FAPi)(2) is safe and unveiled new frontiers to treat various end-stage cancer patients with a theranostic approach.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Ballal, Sanjana | - |
AIIMS - India
All India Institute of Medical Sciences, New Delhi - India |
| 2 | Yadav, Madhav Prasad | Hombre |
AIIMS - India
All India Institute of Medical Sciences, New Delhi - India |
| 3 | Moon, Euy Sung | - |
Johannes Gutenberg Univ Mainz - Alemania
Johannes Gutenberg-Universität Mainz - Alemania |
| 4 | Kramer, Vasko | Hombre |
Positronpharma SA - Chile
|
| 5 | Roesch, F. | Hombre |
Johannes Gutenberg Univ Mainz - Alemania
Johannes Gutenberg-Universität Mainz - Alemania |
| 6 | Kumari, Samta | - |
AIIMS - India
All India Institute of Medical Sciences, New Delhi - India |
| 7 | Bal, Chandrasekhar | - |
AIIMS - India
All India Institute of Medical Sciences, New Delhi - India |
| Agradecimiento |
|---|
| The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of All India Institute of medical Sciences. (The ethical approval number for the clinical use of [68Ga]Ga-DOTA.SA.FAPi, is Ref. No IECPG-22/2020. The ethical approval number for the clinical use of of [177Lu]Lu-labelled FAPi radiotracers Ref. No. IEC/1054/5/2020.). |